181 related articles for article (PubMed ID: 8468470)
21. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings.
Feske S; Müller JM; Graf D; Kroczek RA; Dräger R; Niemeyer C; Baeuerle PA; Peter HH; Schlesier M
Eur J Immunol; 1996 Sep; 26(9):2119-26. PubMed ID: 8814256
[TBL] [Abstract][Full Text] [Related]
22. Differential interaction of nuclear factors with the PRE-I enhancer element of the human IL-4 promoter in different T cell subsets.
Li-Weber M; Salgame P; Hu C; Davydov IV; Krammer PH
J Immunol; 1997 Feb; 158(3):1194-200. PubMed ID: 9013959
[TBL] [Abstract][Full Text] [Related]
23. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.
Paliogianni F; Raptis A; Ahuja SS; Najjar SM; Boumpas DT
J Clin Invest; 1993 Apr; 91(4):1481-9. PubMed ID: 8473495
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
25. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
26. Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1.
Tugores A; Alonso MA; Sánchez-Madrid F; de Landázuri MO
J Immunol; 1992 Apr; 148(7):2300-6. PubMed ID: 1545132
[TBL] [Abstract][Full Text] [Related]
27. An activation-responsive element in single C motif-1/lymphotactin promoter is a site of constitutive and inducible DNA-protein interactions involving nuclear factor of activated T cell.
Yoshida T; Ishikawa I; Ono Y; Imai T; Suzuki R; Yoshie O
J Immunol; 1999 Sep; 163(6):3295-303. PubMed ID: 10477599
[TBL] [Abstract][Full Text] [Related]
28. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
29. AP-1 and ATF-2 are constitutively activated via the JNK pathway in Theileria parva-transformed T-cells.
Botteron C; Dobbelaere D
Biochem Biophys Res Commun; 1998 May; 246(2):418-21. PubMed ID: 9610375
[TBL] [Abstract][Full Text] [Related]
30. NF-AT components define a family of transcription factors targeted in T-cell activation.
Northrop JP; Ho SN; Chen L; Thomas DJ; Timmerman LA; Nolan GP; Admon A; Crabtree GR
Nature; 1994 Jun; 369(6480):497-502. PubMed ID: 8202141
[TBL] [Abstract][Full Text] [Related]
31. p21ras function is important for T cell antigen receptor and protein kinase C regulation of nuclear factor of activated T cells.
Woodrow MA; Rayter S; Downward J; Cantrell DA
J Immunol; 1993 May; 150(9):3853-61. PubMed ID: 8473736
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
Paliogianni F; Boumpas DT
Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
[TBL] [Abstract][Full Text] [Related]
33. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
35. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
36. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
[TBL] [Abstract][Full Text] [Related]
37. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy.
Powell JD; Lerner CG; Ewoldt GR; Schwartz RH
J Immunol; 1999 Dec; 163(12):6631-9. PubMed ID: 10586058
[TBL] [Abstract][Full Text] [Related]
38. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
Gruebele A; Zawaski K; Kaplan D; Novak RF
Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
[TBL] [Abstract][Full Text] [Related]
39. Nuclear factor of activated T cells contains Fos and Jun.
Jain J; McCaffrey PG; Valge-Archer VE; Rao A
Nature; 1992 Apr; 356(6372):801-4. PubMed ID: 1533441
[TBL] [Abstract][Full Text] [Related]
40. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes.
Tamir A; Isakov N
J Immunol; 1994 Apr; 152(7):3391-9. PubMed ID: 8144923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
